2026 NPPES data Addiction Medicine (Internal Medicine) Physician NPI 1639195605 MD
Verify on CMS →

DANA MCGINTY, MD

Addiction Medicine (Internal Medicine) Physician in WASHINGTON, District of Columbia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 175 beneficiaries · Addiction Medicine (Internal Medicine) Physician avg: 1K
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$5.1K
57 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

DANA MCGINTY, MD filed 3,130 Medicare Part D claims in 2023 as a Addiction Medicine (Internal Medicine) Physician in WASHINGTON, District of Columbia, prescribing 82% generic.

3K
Part D claims, 2023
82%
generic prescribing
$5.1K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DANA MCGINTY, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

3,130 Top 11% higher than 89% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

DANA MCGINTY, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DANA MCGINTY, MD?

Quality data not reported

NPI registry status

Active

Issued 07/14/2006

NPI 1639195605

Primary specialty

Addiction Medicine (Internal Medicine) Physician

Niche

553 US NPIs in this specialty

Medicare Part D claims

3,130 123% vs specialty avg

2023 prescription claims

Specialty avg: 1,403

Specialty distribution in District of Columbia

How Addiction Medicine (Internal Medicine) Physician compares to other specialties among District of Columbia providers

District of Columbia providers

Addiction Medicine (Internal Medicine) Physician share within District of Columbia

1. Addiction Medicine (Internal Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Addiction Medicine (Internal Medicine) Physician share within District of Columbia

Specialty board-certification context

Estimated specialty board-certified rate — Addiction Medicine (Internal Medicine) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Addiction Medicine (Internal Medicine) Physician ABMS/AOA estimate

Est. board-certified rate (Addiction Medicine (Internal Medicine) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Addiction Medicine (Internal Medicine) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DANA MCGINTY, MD appears in the CMS NPPES registry as a Addiction Medicine (Internal Medicine) Physician provider holding MD credentials at 1208 CRITTENDEN ST NW, WASHINGTON, DC, 20011, with a listed phone of (202) 882-2565. NPI 1639195605 was issued on 07/14/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MCGINTY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,130 prescription claims written by this provider, covering 175 Medicare beneficiaries and totaling roughly $772K in drug spend, split 18% brand-name and 82% generic by claim count, with an opioid prescribing rate of 0.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Addiction Medicine (Internal Medicine) Physician is a narrow specialty nationwide, with 553 enrolled providers across 46 states and an average of 1,403 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1208 CRITTENDEN ST NW
WASHINGTON, DC 20011

Provider Details

NPI 1639195605
Specialty Addiction Medicine (Internal Medicine) Physician
Credentials MD
Gender Male
NPI Issued 07/14/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DANA MCGINTY, MD. Source: openpaymentsdata.cms.gov.

Total received

$5.1K

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

DANA MCGINTY, MD — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 3,130 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,130
Total Claims
$772K
Total Drug Cost
175
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,764
Total Day Supply
198,532
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$681K
Generic Drug Cost
$89K
Opioid Claims
27 (0.9% rate)
Antibiotic Claims
71

Patient Demographics

Average Patient Age
70.6 years
Avg HCC Risk Score
1.61
Gender Split
55% female / 45% male
Age Distribution
<65: 35, 65-74: 88, 75-84: 36, 85+: 16

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What DANA MCGINTY, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Amlodipine Besylate
164
Atorvastatin Calcium
144
Zolpidem Tartrate
85
Hydrochlorothiazide
84
Tamsulosin Hcl
72
Gabapentin
70
Escitalopram Oxalate
68
Rosuvastatin Calcium
67
Metoprolol Succinate
65
Fluticasone Propionate
64

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction Medicine (Internal Medicine) Physician Overview

How DANA MCGINTY, MD fits within the Addiction Medicine (Internal Medicine) Physician landscape nationally.

553
Addiction Medicine (Internal Medicine) Physician Providers in US
46
States with Addiction Medicine (Internal Medicine) Physician
1,403
Avg Claims per Provider

DANA MCGINTY, MD's 3,130 claims are above the specialty average of 1,403.

Nearby Addiction Medicine (Internal Medicine) Physician Providers in District of Columbia

Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as MCGINTY.

Compare Addiction Medicine (Internal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DANA MCGINTY, MD's specialty?
DANA MCGINTY, MD specializes in Addiction Medicine (Internal Medicine) Physician and practices in WASHINGTON, District of Columbia. Credentials: MD.
How much does DANA MCGINTY, MD prescribe under Medicare Part D?
In 2023, DANA MCGINTY, MD wrote 3,130 Medicare Part D claims totaling $772K in drug costs for 175 beneficiaries.
Where is DANA MCGINTY, MD located?
DANA MCGINTY, MD is located at 1208 CRITTENDEN ST NW, WASHINGTON, DC, 20011. Phone: (202) 882-2565.
What is DANA MCGINTY, MD's NPI number?
DANA MCGINTY, MD's National Provider Identifier (NPI) is 1639195605, issued on 07/14/2006.
Does DANA MCGINTY, MD prescribe more brand-name or generic drugs?
DANA MCGINTY, MD's prescribing is 18% brand-name and 82% generic drugs by claim count, with $681K in brand drug costs.
Does DANA MCGINTY, MD prescribe opioids?
Yes, DANA MCGINTY, MD had 27 opioid claims in 2023 with an opioid prescribing rate of 0.9%.
How many Addiction Medicine (Internal Medicine) Physician providers are there in the US?
There are 553 Addiction Medicine (Internal Medicine) Physician providers across 46 states in the US. The average Addiction Medicine (Internal Medicine) Physician provider writes 1,403 Medicare Part D claims per year.
What drugs does DANA MCGINTY, MD prescribe most often?
Based on 2023 Medicare Part D data, DANA MCGINTY, MD's most frequently prescribed drugs include Amlodipine Besylate, Atorvastatin Calcium, Zolpidem Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DANA MCGINTY, MD accept Medicare?
DANA MCGINTY, MD appears in CMS Medicare data with 3,130 Part D claims and 175 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DANA MCGINTY, MD's credentials?
DANA MCGINTY, MD's NPI is 1639195605 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology